Omalizumab (anti-IgE)
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.
Supplier | Selleck Chemicals |
---|---|
Product # | A2044 |
Sku # | A2044-1mg |
Pricing | 1mg, $249.00 |